Douglas Lane & Associates’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
Other funds holding SNPS
BTCPP
QPBE
MSV
GI
NPPM
JC
BSC
BST
SBWIC
CPBTD
Douglas Lane & Associates's SNPS Position: Q3 2026 in Review
Douglas Lane & Associates increased its Synopsys (SNPS) stake by 19% in Q3 2026, buying an estimated $6.15M and bringing the position to 94,949 shares worth $41.3M. The position accounts for 0.55% of the portfolio, ranked #70.
Douglas Lane & Associates first reported a position in SNPS in Q3 2025 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold SNPS as of Q3 2026.
- Douglas Lane & Associates held 94,949 shares of Synopsys worth $41.3M as of Q3 2026.
- Douglas Lane & Associates bought 15,077 Synopsys shares in Q3 2026, an estimated $6.15M.
- Synopsys made up 0.55% of Douglas Lane & Associates's portfolio in Q3 2026, its #70 holding.
- Douglas Lane & Associates first reported a position in Synopsys in Q3 2025 and has held it in 5 quarters since.
- 54 funds tracked by Wall St. Rank held Synopsys as of Q3 2026.
Based on Douglas Lane & Associates's 13F filing for Q3 2026, filed 9 Oct 2026.